Panagora Asset Management Inc Cytokinetics Inc Transaction History
Panagora Asset Management Inc
- $21.7 Billion
- Q2 2025
A detailed history of Panagora Asset Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 44,635 shares of CYTK stock, worth $2.72 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,635
Previous 47,354
5.74%
Holding current value
$2.72 Million
Previous $1.9 Million
22.54%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
371Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.07 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$731 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$478 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$389 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.75B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...